Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Astellas Pharma : Transfer of Distribution Rights for Targocid® and Maalox®

09/08/2011 | 10:10pm US/Eastern
Recommend:
0

Astellas Pharma Inc. (“Astellas Pharma”; Headquarters: Chuo-ku, Tokyo; President and CEO: Yoshihiko Hatanaka) and sanofi-aventis K.K. (“sanofi-aventis”; Headquarters: Shinjuku-ku, Tokyo; Representative Director and President: Jez Moulding) announced that Astellas Pharma will transfer the rights to distribute the injectable antibiotics Targocid® (generic name: teicoplanin) and the treatment for peptic ulcer and gastritis Maalox® (generic name: dried aluminum hydroxide gel and magnesium hydroxide) to sanofi-aventis effective on January 1, 2012. This transfer of distribution rights is taking place based on the expiration of the contract.

<Products for which distribution rights will be transferred>

Recommend :
0
React to this article
Latest news on ASTELLAS PHARMA INC
1d ago ASTELLAS PHARMA : Vical Reports Second Quarter 2014 Financial Results and Progre..
5d ago ASTELLAS PHARMA : US Inc. Pays $7.3 Million to Resolve False Claims Act Allegati..
7d ago ASTELLAS PHARMA : US Inc. Pays $7.3 Million to Resolve False Claims Act Allegati..
07/23 ASTELLAS PHARMA : New Findings on Pelvic Organ Prolapse Described by Investigato..
07/18 ASTELLAS PHARMA : NC to Share in $7.3 Million Medicaid Fraud Settlement from Ast..
07/16 ASTELLAS PHARMA : Study Data from Astellas Pharma, Inc. Update Understanding of ..
07/15 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Irribow/Irribow ..
07/15 ASTELLAS PHARMA : Attorney General Pam Bondi Announces $7.3 Million Settlement w..
07/15 ASTELLAS PHARMA : Attorney General J.B. Van Hollen Announces Astellas Pharma to ..
07/14 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Irribow®/Irribow..
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
Astellas Pharma Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF